• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


ThermoGenesis Holdings Establishes Rancho Cordova, California, Operations

ThermoGenesis Holdings, Inc., a company involved in automated cell processing and cell and gene therapy services, established operations in Rancho Cordova, California.

The new facility will provide the cleanroom environment, equipment, and services needed for R&D and cGMP manufacturing of cell and gene therapies and other life science products.

"We launched the innovative, flexible ReadyStart cGMP Suites and IncuStart Wet Labs to better support the research and clinical development of cell and gene therapy products. Early-stage life science and cell and gene therapy companies face a long and complex path to product commercialization, often while being constrained by limited budgets," stated Chris Xu, Ph.D., Chairman and Chief Executive Officer of ThermoGenesis. "Our all-encompassing facility will provide a flexible option, enabling companies to achieve their anticipated milestones faster and more efficiently. Additionally, our team's strong expertise in regulatory affairs and product commercialization can help accelerate the development of our customers' products, allowing them to focus on their science, while ThermoGenesis will manage the regulatory and quality compliances associated with running a cGMP facility."

ThermoGenesis Holdings, Inc. is an industry leader in the development and commercialization of automated cell processing technologies for the cell and gene therapy fields. The company offers a full suite of solutions for automated clinical biobanking, point-of-care applications, and large scale cellular processing and manufacturing for the emerging CAR-T immunotherapy market.

"We are thrilled ThermoGenesis is in our market, specifically in Rancho Cordova, building the world-class ReadyStart Cleanrooms and IncuStart Wet Labs for the Sacramento region," Greater Sacramento Economic Council President & CEO Barry Broome noted. "This incubator facility will allow scientists to develop and commercialize their product providing new cell and gene therapy technologies."

Exclusive Research